OTAVA-BB BB7018611136
- $105 - $399
- Product name: OTAVA-BB BB7018611136
- CAS: 90027-14-8
- MF: C14H11Cl4NO4
- MW: 399.05
- EINECS:
- MDL Number:MFCD02319303
- Synonyms:OTAVA-BB BB7018611136;4-Methyl-2-(4,5,6,7-tetrachloro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)pentanoic acid;4-Methyl-2-(4,5,6,7-tetrachloro-1,3-dioxoisoindolin-2-yl)pentanoic acid;2H-Isoindole-2-acetic acid, 4,5,6,7-tetrachloro-1,3-dihydro-α-(2-methylpropyl)-1,3-dioxo-
3 prices
Selected condition:
Brand
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerMatrix Scientific
- Product number077147
- Product description4-Methyl-2-(4,5,6,7-tetrachloro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)pentanoic acid
- Packaging500mg
- Price$105
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number077147
- Product description4-Methyl-2-(4,5,6,7-tetrachloro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)pentanoic acid
- Packaging1g
- Price$126
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number077147
- Product description4-Methyl-2-(4,5,6,7-tetrachloro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)pentanoic acid
- Packaging5g
- Price$399
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Matrix Scientific | 077147 | 4-Methyl-2-(4,5,6,7-tetrachloro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)pentanoic acid | 500mg | $105 | 2021-12-16 | Buy |
Matrix Scientific | 077147 | 4-Methyl-2-(4,5,6,7-tetrachloro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)pentanoic acid | 1g | $126 | 2021-12-16 | Buy |
Matrix Scientific | 077147 | 4-Methyl-2-(4,5,6,7-tetrachloro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)pentanoic acid | 5g | $399 | 2021-12-16 | Buy |
Properties
Boiling point :569.7±50.0 °C(Predicted)
Density :1.615±0.06 g/cm3(Predicted)
pka :3.22±0.21(Predicted)
Density :1.615±0.06 g/cm3(Predicted)
pka :3.22±0.21(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|